ATE258440T1 - Verwendung von neutralen gallium chelaten mit 3- hydroxy-4-pyrone verbindungen zur behandlung von krankheiten die verbessert werden können durch die hemmung der hyperproliferation von keratinocyten - Google Patents
Verwendung von neutralen gallium chelaten mit 3- hydroxy-4-pyrone verbindungen zur behandlung von krankheiten die verbessert werden können durch die hemmung der hyperproliferation von keratinocytenInfo
- Publication number
- ATE258440T1 ATE258440T1 AT97938025T AT97938025T ATE258440T1 AT E258440 T1 ATE258440 T1 AT E258440T1 AT 97938025 T AT97938025 T AT 97938025T AT 97938025 T AT97938025 T AT 97938025T AT E258440 T1 ATE258440 T1 AT E258440T1
- Authority
- AT
- Austria
- Prior art keywords
- keratinocytes
- diseases
- hydroxy
- treatment
- improved
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/688,565 US5747482A (en) | 1996-07-30 | 1996-07-30 | Methods and compositions to inhibit keratinocyte proliferation |
PCT/US1997/012951 WO1998004264A1 (en) | 1996-07-30 | 1997-07-30 | Methods and compositions to inhibit keratinocyte proliferation |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE258440T1 true ATE258440T1 (de) | 2004-02-15 |
Family
ID=24764914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97938025T ATE258440T1 (de) | 1996-07-30 | 1997-07-30 | Verwendung von neutralen gallium chelaten mit 3- hydroxy-4-pyrone verbindungen zur behandlung von krankheiten die verbessert werden können durch die hemmung der hyperproliferation von keratinocyten |
Country Status (8)
Country | Link |
---|---|
US (1) | US5747482A (de) |
EP (1) | EP0959889B1 (de) |
JP (1) | JP2000516219A (de) |
AT (1) | ATE258440T1 (de) |
AU (2) | AU3726797A (de) |
DE (1) | DE69727399T2 (de) |
ES (1) | ES2214635T3 (de) |
WO (2) | WO1998004263A1 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6203822B1 (en) * | 1996-09-03 | 2001-03-20 | University Of Iowa Research Foundation | Gallium-containing compounds for the treatment of infections caused by intracellular pathogens and pathogens causing chronic pulmonary infection |
DE60032915T2 (de) * | 1999-10-04 | 2007-10-25 | Bernstein, Lawrence Richard, Dr., Menlo Park | Gallium komplexe von 3-hydroxy-4-pyronen zur behandlung von durch intrazelluläre prokaryoten, dns- und retro-viren verursachten infektionen |
US20020160055A1 (en) * | 2000-09-18 | 2002-10-31 | Jack Stapleton | Methods for treating human immunodeficiency virus infections with gallium compositions |
JP2004292314A (ja) * | 2000-12-14 | 2004-10-21 | Chugai Pharmaceut Co Ltd | ケラチノサイト増殖抑制剤 |
JP2003267966A (ja) * | 2002-03-13 | 2003-09-25 | Pola Chem Ind Inc | フラバン誘導体、皮膚線維芽細胞増殖抑制剤および皮膚外用剤 |
US7081247B2 (en) * | 2002-05-20 | 2006-07-25 | Nidaria Technology Ltd. | Composition and method for inhibiting polar capsule discharge and protecting a subject from nematocyst sting |
US7119217B2 (en) * | 2002-09-23 | 2006-10-10 | Genta Incorporated | Tri(alkylcarboxylato)gallium (III) products and pharmaceutical compositions containing them |
EP1993567A4 (de) * | 2005-10-27 | 2011-01-26 | Lawrence Richard Bernstein | Oral verabreichbare gallium-zusammensetzungen und anwendungsverfahren |
CN101484178A (zh) | 2005-11-01 | 2009-07-15 | 赛德罗米克斯有限责任公司 | 使用镓化合物的口部和表面微生物的生长控制 |
CN101300033A (zh) * | 2005-11-07 | 2008-11-05 | 泰坦医药品公司 | 用镓对不良肝脏病症的治疗和预防 |
EP1978976A2 (de) * | 2006-01-30 | 2008-10-15 | Titan Pharmaceuticals, Inc. | Verwendung von gallium zur behandlung von biofilm-assoziierten infektionen |
US8168214B2 (en) * | 2006-11-09 | 2012-05-01 | Bernstein Lawrence R | Local administration of gallium compositions to treat pain |
US20080292726A1 (en) * | 2007-01-23 | 2008-11-27 | Bernstein Lawrence R | Ophthalmic gallium compositions and methods of their use |
US20080175922A1 (en) * | 2007-01-23 | 2008-07-24 | Bernstein Lawrence R | Ophthalmic gallium compositions and methods of their use |
WO2009009171A2 (en) * | 2007-04-02 | 2009-01-15 | Sideromics, Llc | Methods for preventing or treating infectious diseases using gallium compounds |
ES2336995B1 (es) * | 2008-10-13 | 2011-02-09 | Lipotec, S.A. | Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas. |
WO2016092493A1 (en) * | 2014-12-12 | 2016-06-16 | Glaxosmithkline Intellectual Property Development Limited | Novel method of use |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2500303A1 (fr) * | 1981-02-20 | 1982-08-27 | Meram Lab | Le chlorure de gallium, nouveau medicament anti-cancereux |
DE3376387D1 (en) * | 1982-10-22 | 1988-06-01 | Sloan Kettering Inst Cancer | The use of gallium salts for the manufacture of pharmaceutical compositions for the treatment of disorders of calcium homeostasis |
US4704277A (en) * | 1985-04-30 | 1987-11-03 | Sloan-Kettering Institute For Cancer Research | Methods of treating bone disorders |
US5258376A (en) * | 1989-11-22 | 1993-11-02 | Bernstein Lawrence R | Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |
KR100196773B1 (ko) * | 1990-01-12 | 1999-06-15 | 워얼렐 에스. 브로우;도날드 에스. 브로아즈 | 상처치유 및 조직회복을_향상시키기 위한 조성물 |
AU7981791A (en) * | 1990-05-24 | 1991-12-10 | Fujisawa, Inc. | Orally administrable gallium compositions and methods of treatment therewith |
US5175006A (en) * | 1990-09-21 | 1992-12-29 | The Ohio State University | Method of treating arthritis using gallium compounds |
JP3348849B2 (ja) * | 1991-11-12 | 2002-11-20 | ローレンス リチャード バーンスタイン | 3−ヒドロキシ−4−ピロンのガリウム錯体の医薬組成物 |
-
1996
- 1996-07-30 US US08/688,565 patent/US5747482A/en not_active Expired - Lifetime
-
1997
- 1997-07-15 AU AU37267/97A patent/AU3726797A/en not_active Abandoned
- 1997-07-15 WO PCT/US1997/012197 patent/WO1998004263A1/en active Application Filing
- 1997-07-30 AT AT97938025T patent/ATE258440T1/de not_active IP Right Cessation
- 1997-07-30 DE DE69727399T patent/DE69727399T2/de not_active Expired - Lifetime
- 1997-07-30 JP JP10508959A patent/JP2000516219A/ja not_active Ceased
- 1997-07-30 ES ES97938025T patent/ES2214635T3/es not_active Expired - Lifetime
- 1997-07-30 EP EP97938025A patent/EP0959889B1/de not_active Expired - Lifetime
- 1997-07-30 AU AU40446/97A patent/AU740198B2/en not_active Ceased
- 1997-07-30 WO PCT/US1997/012951 patent/WO1998004264A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
AU740198B2 (en) | 2001-11-01 |
ES2214635T3 (es) | 2004-09-16 |
WO1998004264A1 (en) | 1998-02-05 |
DE69727399D1 (de) | 2004-03-04 |
DE69727399T2 (de) | 2004-12-09 |
WO1998004263A1 (en) | 1998-02-05 |
JP2000516219A (ja) | 2000-12-05 |
US5747482A (en) | 1998-05-05 |
EP0959889B1 (de) | 2004-01-28 |
AU3726797A (en) | 1998-02-20 |
AU4044697A (en) | 1998-02-20 |
EP0959889A1 (de) | 1999-12-01 |
EP0959889A4 (de) | 2000-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE258440T1 (de) | Verwendung von neutralen gallium chelaten mit 3- hydroxy-4-pyrone verbindungen zur behandlung von krankheiten die verbessert werden können durch die hemmung der hyperproliferation von keratinocyten | |
ATE192652T1 (de) | Zusammensetzung zur behandlung von preeclampsia und frühgeburt, die ein progestatives mittel und ein stickoxyd-synthäse substrat und/oder donor enthält | |
DE3482754D1 (de) | Medikament und medikamentoese zusammensetzung zur behandlung und/oder verhinderung von hautkrankheiten, verursacht durch eine entzuendung. | |
DE60115000D1 (de) | Die Verwendung von Prostaglandin F Analoga zur Herstellung von Zusammensetzungen für die Behandlung von Haarausfall. | |
DE69512374D1 (de) | Zusammensetzungen, die troxerutin als komplex mit phosphatidylcholin enthalten, zur topischen behandlung von erektionsimpotenz | |
MY101353A (en) | Arylcarboxylic acid derivatives, the preparation and use thereof. | |
ATE342278T1 (de) | Verfahren zur behandlung von diabetes mittels kgf | |
DE69731477D1 (de) | Mittel zur akne behandlung | |
ATE236643T1 (de) | Verwendung von calendula-glykosiden zur behandlung der psoriasis | |
DE60021381D1 (de) | Chinonverbindungen zur behandlung von krankheiten | |
ATE272404T1 (de) | Verwendung von taurolidine zur herstellung eines arzneimittels zur behandlung von leukämien | |
FR2451745A1 (fr) | Procede de preparation d'immunoglobuline pour administration par voie intraveineuse | |
DE60009919D1 (de) | Antimikrobieller bodensatz | |
DE69904203D1 (de) | Thiomolybdat verbunden mit mindestens einem kohlenhydrat, und seine verwendung zur vorbeugung und behandlung von erkrankungen, die durch eine anormale vaskularisierung gekennzeichnet sind, wie z.b. krebs, "feuchte" makuladegeneration, rheumatoide arthritis | |
ATE183097T1 (de) | Zusammensetzung und methode zur behandlung von störungen in form von depigmentierung | |
DE60026883D1 (de) | Methoden und zusammensetzungen zur behandlung von schmerzen | |
ATE75396T1 (de) | Verwendung von kojic-saeure oder ihres betacyclodextrin-einschlusskomplexes zur praevention von elastosis. | |
ATE251462T1 (de) | Verfahren zur behandlung von narbengewebe | |
DE59900286D1 (de) | Verwendung von sphingosin-1-phosphat, sphingosin-1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten | |
DE60119285D1 (de) | Verwendung von plgf zur vorbeugung oder behandlung von ischaemie oder schlaganfall | |
DK0669834T3 (da) | Anvendelse af topisk påført faktor Xlll til inhibering af blødning | |
ATE365718T1 (de) | Substituierte 11-phenyl-dibenzazepin-verbindungen,die nützlich sind zur behandlung oder vorbeugung von durch abnormale zellproliferation gekennzeichneten krankheiten | |
FR2455610A1 (fr) | Nouveaux steroides inhibiteurs de la 5a-reductase, utiles notamment pour le traitement de l'acne et leur procede de preparation | |
ATE209040T1 (de) | Verfahren und zusammensetzungen zur verhinderung von entzündungen, die durch endothelzellen und fibrinogen ausgelöst werden | |
DK162440C (da) | Pyrazindiazohydroxidforbindelser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |